Literature DB >> 23088957

Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature.

Orazio Caffo1, Antonello Veccia, Gianni Fellin, Lucianna Russo, Salvatore Mussari, Enzo Galligioni.   

Abstract

Although radical cystectomy is still the treatment of choice for patients with infiltrating bladder cancer, there is growing evidence of the effectiveness of a conservative approach. Developed as a treatment of need for elderly or unfit patients unable to undergo radical cystectomy, conservative therapy is becoming a true alternative to surgery for highly selected patients. Although transurethral bladder resection, external radiotherapy and systemic chemotherapy can control the disease as single treatments, the best results have been observed when they are combined. Moreover, new irradiation techniques and new-generation drugs are now being tested in an attempt to improve disease control further. Conservative management requires the multidisciplinary involvement of different specialties in order to give patients a real alternative to surgical treatment.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088957     DOI: 10.1016/j.critrevonc.2012.09.011

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  6 in total

1.  Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Authors:  Girish S Kulkarni; Peter C Black; Srikala S Sridhar; Anil Kapoor; Alexandre R Zlotta; Bobby Shayegan; Ricardo A Rendon; Peter Chung; Theodorus van der Kwast; Nimira Alimohamed; Yves Fradet; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2019-01-31       Impact factor: 1.862

2.  Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.

Authors:  Evren Suer; Nurullah Hamidi; Mehmet Ilker Gokce; Omer Gulpinar; Kadir Turkolmez; Yasar Beduk; Sumer Baltaci
Journal:  World J Urol       Date:  2015-10-13       Impact factor: 4.226

3.  GUROPA survey: genito-urinary radiation oncology prescription attitudes.

Authors:  Sergio Fersino; Stefano Arcangeli; Barbara Alicja Jereczek-Fossa; Rolando D'Angelillo; Filippi Bertoni; Giuseppe Roberto D'Agostino; Luca Triggiani; Renzo Corvò; Stefano Maria Magrini; Filippo Alongi
Journal:  Radiol Med       Date:  2018-07-13       Impact factor: 3.469

4.  Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice.

Authors:  Han-Ning Huang; Venugopal Rajanbabu; Chieh-Yu Pan; Yi-Lin Chan; Jyh-Yih Chen; Chang-Jer Wu
Journal:  Mar Drugs       Date:  2015-05-21       Impact factor: 5.118

Review 5.  Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.

Authors:  Marga Garrido Siles; Antonio López-Beltran; Paula Pelechano; Ana María García Vicente; Regina Gironés Sarrió; Eva González-Haba Peña; Alfredo Rodríguez Antolín; Almudena Zapatero; José Ángel Arranz; Miguel Ángel Climent
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

6.  Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.

Authors:  Cheng-Yen Lee; Kai-Lin Yang; Hui-Ling Ko; Rong-Yau Huang; Pei-Pin Tsai; Ming-Tsun Chen; Yi-Chia Lin; Thomas I-Sheng Hwang; Guang-Dar Juang; Kwan-Hwa Chi
Journal:  Radiat Oncol       Date:  2014-09-24       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.